Show simple item record

dc.contributor.authorBastien, Krumm
dc.contributor.authorLundby, Carsten
dc.contributor.authorHansen, Joar
dc.contributor.authorJacob, Bejder
dc.contributor.authorHenrik, Sørensen
dc.contributor.authorTristan, Equey
dc.contributor.authorJonas, Saugy
dc.contributor.authorFrancesco, Botrè
dc.contributor.authorRaphael, Faiss
dc.date.accessioned2025-03-13T07:46:26Z
dc.date.available2025-03-13T07:46:26Z
dc.date.created2024-02-21T13:46:56Z
dc.date.issued2024
dc.identifier.citationDrug Testing and Analysis. 2024, 16 (11), 1285-1294.en_US
dc.identifier.issn1942-7603
dc.identifier.urihttps://hdl.handle.net/11250/3183153
dc.description.abstractConfounding factors including exercise and environments challenge the interpretation of individual Athlete Biological Passports (ABPs). This study aimed to investigate the natural variability of hematological ABP parameters over 1 year in elite athletes compared with healthy control subjects and the validity of a multiparametric model estimating plasma volume (PV) shifts to correct individual ABP thresholds. Blood samples were collected monthly with full blood counts performed by flow cytometry (Sysmex XN analyzers) in 20 elite xc-skiers (ELITE) and 20 moderately trained controls. Individual ABP profiles were generated through Anti-Doping Administration & Management System Training, a standalone version of the ABP's adaptive model developed by the World Anti-Doping Agency. Additionally, eight serum parameters were computed as volume-sensitive biomarkers to run a multiparametric model to estimate PV. Variability in ELITE compared with controls was significantly higher for the Abnormal Blood Profile Scores (P = 0.003). Among 12 Atypical Passport Findings (ATPF) initially reported, six could be removed after correction of PV shifts with the multiparametric modeling. However, several ATPF were additionally generated (n = 19). Our study outlines a larger intraindividual variability in elite athletes, likely explained by more frequent exposure to extrinsic factors altering hematological biomarkers. PV correction for individual ABP thresholds allowed to explain most of the atypical findings while generating multiple new ATPF occurrences in the elite population. Overall, accounting for PV shifts in elite athletes was shown to be paramount in this study outlining the opportunity to consider PV variations with novel approaches when interpreting individual ABP profiles.
dc.language.isoengen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleYearly intrasubject variability of hematological biomarkers in elite athletes for the Athlete Biological Passporten_US
dc.title.alternativeYearly intrasubject variability of hematological biomarkers in elite athletes for the Athlete Biological Passporten_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersion
dc.source.pagenumber1285-1294en_US
dc.source.volume16en_US
dc.source.journalDrug Testing and Analysisen_US
dc.source.issue11en_US
dc.identifier.doi10.1002/dta.3645
dc.identifier.cristin2248494
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal